Figure S6+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
Liting Zhou(Zhengzhou University), Zigang Dong(China-US (Henan) Hormel Cancer Institute), Tingxuan Gu(Zhengzhou University), Yijie Ma(Henan Cancer Hospital), Mee‐Hyun Lee(Dongshin University), Bingbing Lu(Zhengzhou University), Xiaojie Chen(Zhengzhou University), Wenna Nie(China-US (Henan) Hormel Cancer Institute), Jiutao Wang(Zhengzhou University), Ran Zhao(Zhengzhou University), Hui Luo(Zhengzhou University), Xiang Li(Zhengzhou University), Jie Tian(Zhengzhou University), Xuejiao Liu(Xuzhou Medical College), Nan Wang(Ministry of Education), Keke Wang(Zhengzhou University), Wenting Liu(Zhengzhou University), Penglei Wang(Zhengzhou University), Hong Ge(Zhengzhou University), Simin Zhao(Georgia Institute of Technology), Kangdong Liu(Zhengzhou University)
Cited by 0
Related Papers
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|Proceedings of the National Academy of Sciences|1994|390
Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells
|Proceedings of the National Academy of Sciences|1998|201
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
|Journal of Hematology & Oncology|2022|178
Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
|PubMed|1996|138
Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK
|Carcinogenesis|2011|123